Literature DB >> 823588

Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats.

R A Yokel, R A Wise.   

Abstract

Norepinephrine (NE) and dopamine (DA) receptor blockade differentially affected amphetamine self-administration. DA blockade (pimozide, 0.0625 to 0.5 mg/kg, or (+)-butaclamol, 0.0125 to 0.1 mg/kg) caused periods of increased rate of responding for amphetamine which were followed, in the case of higher doses, by response cessation. The response cessation produced by 0.5 mg/kg pimozide was not reversed by non-contingent amphetamine injections until well after the peak effect of the pimozide was over. When access to amphetamine injections was delayed until 4 h after animals received 0.5 mg/kg pimozide, rate of responding was elevated. Thus DA seems to be critically involved in mediation of the reinforcing effects of amphetamine. Alpha-NE blockade with phentolamine (2.5-10 mg/kg) produced dose-related decreases in responding; blockade with phenoxybenzamine (1.25-10 mg/kg) had no effect. Beta-NE blockade with l-propranolol (2.5-10 mg/kg) decreased responding, although probably not through a beta-blocking action. The effects of phentolamine and propranolol do not appear to result from attenuation of the reinforcing effects of amphetamine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 823588     DOI: 10.1007/BF00496868

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits.

Authors:  G Fouriezos; R A Wise
Journal:  Brain Res       Date:  1976-02-20       Impact factor: 3.252

2.  Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum.

Authors:  R J Miller; A S Horn; L L Iversen
Journal:  J Pharm Pharmacol       Date:  1975-03       Impact factor: 3.765

3.  Effect of haloperidol on (+)-amphetamine self-administration.

Authors:  W M Davis; S G Smith
Journal:  J Pharm Pharmacol       Date:  1975-07       Impact factor: 3.765

4.  Aminergic influences on intravenous cocaine self-administration by Rhesus monkeys.

Authors:  M C Wilson; C R Schuster
Journal:  Pharmacol Biochem Behav       Date:  1974 Sep-Oct       Impact factor: 3.533

5.  Self-administration of optical isomers of amphetamine and methylamphetamine by rats.

Authors:  R A Yokel; R Pickens
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

6.  Stereotyped activities produced by amphetamine in several animal species and man.

Authors:  A Randrup; I Munkvad
Journal:  Psychopharmacologia       Date:  1967

7.  Cocaine-reinforced behavior in rats: effects of reinforcement magnitude and fixed-ratio size.

Authors:  R Pickens; T Thompson
Journal:  J Pharmacol Exp Ther       Date:  1968-05       Impact factor: 4.030

Review 8.  Mode of action of beta receptor antagonists on cardiac muscle.

Authors:  E M Williams
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

9.  Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward.

Authors:  R A Yokel; R A Wise
Journal:  Science       Date:  1975-02-14       Impact factor: 47.728

10.  The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.

Authors:  K Voith; F Herr
Journal:  Psychopharmacologia       Date:  1975-04-30
View more
  66 in total

1.  Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine.

Authors:  R Ranaldi; R A Wise
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

2.  Blockade of substantia nigra dopamine D1 receptors reduces intravenous cocaine reward in rats.

Authors:  Matthew G Quinlan; Ruth Sharf; David Y Lee; Roy A Wise; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2004-02-07       Impact factor: 4.530

3.  The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.

Authors:  Arlene C Pak; Charles R Ashby; Christian A Heidbreder; Maria Pilla; Jeremy Gilbert; Zheng-Xiong Xi; Eliot L Gardner
Journal:  Int J Neuropsychopharmacol       Date:  2006-08-31       Impact factor: 5.176

4.  Enhanced nicotine self-administration and suppressed dopaminergic systems in a rat model of diabetes.

Authors:  Laura E O'Dell; Luis A Natividad; Joseph A Pipkin; Francisco Roman; Ivan Torres; Jesus Jurado; Oscar V Torres; Theodore C Friedman; John M Tenayuca; Arbi Nazarian
Journal:  Addict Biol       Date:  2013-07-08       Impact factor: 4.280

5.  Discrete-trials heroin self-administration produces sensitization to the reinforcing effects of cocaine in rats.

Authors:  Sara J Ward; Christopher Läck; Drake Morgan; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2006-01-14       Impact factor: 4.530

Review 6.  Dopamine and reward: the anhedonia hypothesis 30 years on.

Authors:  Roy A Wise
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

7.  Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine.

Authors:  P J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

8.  6-Hydroxydopamine lesion of the dopamine mesocorticolimbic cell bodies increases (+)-amphetamine self-administration.

Authors:  J M Deminière; H Simon; J P Herman; M Le Moal
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats.

Authors:  H O Pettit; A Ettenberg; F E Bloom; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin.

Authors:  E A Loh; D C Roberts
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.